Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer

By Chu Huili   Zhong Chen   Xue Guoliang   Liang Xiuju   Wang Jun   Liu Yingxin   Zhao Shiwei   Zhou Qian   Bi Jingwang  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2311-2315

Spandidos Publications

Access to resources Recommend Favorite

Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer

By Riedel Richard F   Febbo Phillip G  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 461-466

Future Medicine

Access to resources Recommend Favorite

A Comparison of Epidermal Growth Factor Receptor Levels and Other Prognostic Parameters in Non-small Cell Lung Cancer

By Fujino S.   Enokibori T.   Tezuka N.   Asada Y.   Inoue S.   Kato H.   Mori A.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2070-2074

Elsevier

Access to resources Recommend Favorite

Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

By Ayoola Ayodele   Barochia Amit   Belani Kiran   Belani Chandra P.  

Cancer Investigation, Vol. 30, Iss. 5, 2012-05 ,pp. : 433-446

Informa Healthcare

Access to resources Recommend Favorite

Association of epidermal growth factor receptor and KRas mutations with smoking history in nonsmall cell lung cancer patients

By              

Experimental and Therapeutic Medicine, Vol. 5, Iss. 2, 2013-01 ,pp. : 495-498

Spandidos Publications

Access to resources Recommend Favorite